New group care model aims to help moms in recovery and their babies
NCT ID NCT05488379
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a group well child care program for mothers in treatment for opioid use disorder and their infants. Instead of standard one-on-one checkups, mother-infant pairs attended group visits together from 1 to 18 months of age. The goal was to see if this approach improves healthcare engagement, parenting knowledge, and mother-child interaction quality.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- group well child care (CenteringParenting)
- What this could lead to
- If successful, this group care model could improve healthcare engagement and parenting skills for mothers recovering from opioid use disorder and their infants.
- What could go wrong
- This is a small, completed study with 49 participants, so results may not apply broadly. The intervention is behavioral, not a drug, so benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tool better measure opioid withdrawal?
- Giving patients a voice in methadone care: a new approach under the microscope
- Can a sleep pill boost success in opioid treatment?
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Could a trip to the pediatrician help teens beat opioid addiction?
- A nose spray before treatment: could naloxone speed up opioid recovery for fentanyl users?